Replies to post #216515 on Biotech Values

[DewDiligence]

Abbvie and ENTA produced a HCV drug treatment without a nuke. No one thought this possible/likely/prudent…

Actually, I posted back in 2011 that a nuke was not an obligate component of an HCV regimen: #msg-69562412.

But you’re correct in stating that few people at the time thought a nuke-free all-oral regimen would work.

[DewDiligence]

Agreed—ENTA's CEO, Jay Luly has more spring in his step than at any time in recent years.